[更年期,激素治疗和心血管风险]
Geneviève Plu-Bureau1, Iphigénie Cavadias1, Brigitte Raccah-Tebeka2
1Unité de gynécologie endocrinienne, hôpital Port-Royal, Université Paris Cité, Paris, Inserm UMR 1153, Obstetrical, Perinatal, Paediatric Life course Epidemiology (OPPaLE), centre d'épidémiologie et de statistiques Sorbonne Paris Cité (CRESS), Paris, France.
概括
更年期是女性查心血管疾病风险因素的理想时间. 透皮雌激素和天然孕激素为符合条件的妇女提供最安全的激素治疗,需要每年进行风险评估.
科学领域:
- 心脏病学 心脏病学
- 妇女健康 妇女健康
- 内分泌学 在内分泌学.
背景情况:
- 心血管疾病 (CVD) 是法国妇女的主要死亡原因.
- 更年期为评估心血管风险提供了一个关键的窗口.
- 致残的高潮期综合征往往需要考虑治疗.
研究的目的:
- 强调在更年期期间进行心血管风险查的重要性.
- 评估更年期激素治疗 (MHT) 的安全性和有效性.
- 为有高潮综合征的妇女推最佳的MHT.
主要方法:
- 审查目前的临床指导方针和关于绝经妇女心血管疾病风险因素的文献.
- 对不同MHT配方的安全性分析.
- 强调每年对MHT管理进行后续行动的必要性.
主要成果:
- 更年期被确定为全面的心血管风险因素查的最佳时期.
- 通过皮肤注射的雌激素与天然孕激素结合,被认为是没有子宫切除病史的女性最安全的MHT选择.
- 每年对治疗耐受性和心血管风险因素的评估至关重要.
结论:
- 在更年期期间进行系统的心血管风险查是必不可少的.
- 特定的MHT配方 (透皮雌激醇/天然孕激素) 为特定的妇女提供了有利的益处/风险概况.
- 持续监测对于优化MHT安全性和有效性至关重要.
相关概念视频
Menopause
3.5K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
3.5K
Hormonal Regulation of the Menstrual Cycle
1.4K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
1.4K
Hormonal Regulation of Blood Pressure
5.8K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
5.8K
Psychoneuroimmunology: Cardiovascular Disease
382
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
382
Mitral Valve Prolapse III: Nursing Management
279
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
279
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
915
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
915


